| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5692583 | European Urology | 2016 | 8 Pages |
Abstract
Low-grade clinical Ta papillary recurrence following induction of bacillus Calmette-Guérin therapy can be safely managed conservatively, although a high-grade clinical Ta recurrence should be treated similar to a clinical T1 recurrence due to its comparable progression rates.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Chinedu O. Mmeje, Charles C. Guo, Jay B. Shah, Neema Navai, H. Barton Grossman, Colin P. Dinney, Ashish M. Kamat,